1. Home
  2. FTK vs KMDA Comparison

FTK vs KMDA Comparison

Compare FTK & KMDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Flotek Industries Inc.

FTK

Flotek Industries Inc.

HOLD

Current Price

$19.86

Market Cap

720.7M

Sector

Industrials

ML Signal

HOLD

Logo Kamada Ltd.

KMDA

Kamada Ltd.

HOLD

Current Price

$7.82

Market Cap

454.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FTK
KMDA
Founded
1985
1990
Country
United States
Israel
Employees
160
N/A
Industry
Major Chemicals
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
720.7M
454.0M
IPO Year
1997
2013

Fundamental Metrics

Financial Performance
Metric
FTK
KMDA
Price
$19.86
$7.82
Analyst Decision
Buy
Strong Buy
Analyst Count
1
2
Target Price
$20.00
$14.00
AVG Volume (30 Days)
226.8K
48.0K
Earning Date
05-05-2026
05-13-2026
Dividend Yield
N/A
3.08%
EPS Growth
147.06
N/A
EPS
0.12
N/A
Revenue
$136,092,000.00
N/A
Revenue This Year
$13.33
$13.94
Revenue Next Year
$16.38
$9.84
P/E Ratio
$171.17
$24.59
Revenue Growth
214.53
N/A
52 Week Low
$10.96
$6.50
52 Week High
$20.99
$9.35

Technical Indicators

Market Signals
Indicator
FTK
KMDA
Relative Strength Index (RSI) 64.95 42.10
Support Level $15.01 $7.66
Resistance Level $20.25 $8.55
Average True Range (ATR) 1.41 0.21
MACD 0.29 -0.04
Stochastic Oscillator 67.71 36.15

Price Performance

Historical Comparison
FTK
KMDA

About FTK Flotek Industries Inc.

Flotek Industries Inc is a technology-driven specialty chemistry and data company. It has two reportable segments: Its Chemistry Technologies segment includes specialty chemistries, logistics and technology services. It also include integrated oil and gas companies, oilfield services companies, independent oil and gas companies, national and state-owned oil companies, and international supply chain management companies. The Data Analytics segment provides analytical measurement solutions and deliver real-time information and insights to customers to enable optimization of operations and reduction of emissions and their carbon intensity. Key revenue comes from its Chemistry Technologies segment.

About KMDA Kamada Ltd.

Kamada Ltd is a drug-focused, plasma-derived protein therapeutics company. It is involved in the business of developing, producing, and marketing specialty therapeutics using protein purification proprietary technology. Its product portfolio consists of Glassia, Bramitob, Foster, Ixiaro, Factor-IX, and others. The company has two segments namely, the Proprietary Products segment and the Distribution segment. It derives the majority of its revenue from the Proprietary products segment. The firm categorizes its products in Lung Disease, Vaccines, Haemophilia, Immunoglobulins, Critical care, and Diagnostics.

Share on Social Networks: